Pediatric Pulmonology year in review 2017: Part 3
dc.contributor.author | Ren C.L. | |
dc.contributor.author | Muston H.N. | |
dc.contributor.author | Yilmaz O. | |
dc.contributor.author | Noah T.L. | |
dc.date.accessioned | 2024-07-22T08:09:45Z | |
dc.date.available | 2024-07-22T08:09:45Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Pediatric Pulmonology publishes original research, reviews, and case reports related to a wide range of children's respiratory disorders. We here summarize the past year's publications in our major topic areas, in the context of selected literature in these areas from other journals relevant to our discipline. This review (Part 3 of a 5-part series) covers selected articles on asthma, physiology/lung function testing, and respiratory infections. © 2018 Wiley Periodicals, Inc. | |
dc.identifier.DOI-ID | 10.1002/ppul.24052 | |
dc.identifier.issn | 87556863 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14950 | |
dc.language.iso | English | |
dc.publisher | John Wiley and Sons Inc. | |
dc.rights | All Open Access; Green Open Access | |
dc.subject | Asthma | |
dc.subject | Humans | |
dc.subject | Pediatrics | |
dc.subject | Pulmonary Medicine | |
dc.subject | Respiratory Function Tests | |
dc.subject | Respiratory Tract Infections | |
dc.subject | antibiotic agent | |
dc.subject | dexamethasone | |
dc.subject | mometasone furoate | |
dc.subject | omalizumab | |
dc.subject | placebo | |
dc.subject | prednisolone | |
dc.subject | air pollution | |
dc.subject | Aspergillus fumigatus | |
dc.subject | asthma | |
dc.subject | bacterial pneumonia | |
dc.subject | bronchiolitis | |
dc.subject | community acquired pneumonia | |
dc.subject | cystic fibrosis | |
dc.subject | diffusion coefficient | |
dc.subject | disease severity | |
dc.subject | drug exposure | |
dc.subject | evidence based practice | |
dc.subject | exercise test | |
dc.subject | forced expiratory volume | |
dc.subject | high risk population | |
dc.subject | human | |
dc.subject | interferon gamma release assay | |
dc.subject | lung diffusion capacity | |
dc.subject | lung function | |
dc.subject | lung function test | |
dc.subject | mental stress | |
dc.subject | Mycobacterium tuberculosis | |
dc.subject | neonatal intensive care unit | |
dc.subject | pediatrics | |
dc.subject | physiology | |
dc.subject | positive end expiratory pressure | |
dc.subject | priority journal | |
dc.subject | psychological aspect | |
dc.subject | publication | |
dc.subject | pulmonology | |
dc.subject | pyrosequencing | |
dc.subject | respiratory syncytial virus infection | |
dc.subject | respiratory tract infection | |
dc.subject | respiratory tract parameters | |
dc.subject | Review | |
dc.subject | risk factor | |
dc.subject | social psychology | |
dc.subject | tuberculosis | |
dc.subject | viral bronchiolitis | |
dc.subject | wheezing | |
dc.subject | asthma | |
dc.title | Pediatric Pulmonology year in review 2017: Part 3 | |
dc.type | Review |